Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Modular Medical secured a national PBM contract to expand access to its Pivot tubeless insulin patch pump for patients managing diabetes.
Stocks · News reference
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
Modular Medical receives FDA clearance for software enhancements to its Pivot insulin delivery system ahead of its planned Q4 launch.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Modular Medical Receives Contract From Undisclosed U.S. Pharmacy Benefit Manager To Provide Its Insulin Delivery System
Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump,
8-K filing — Modular Medical, Inc. (MODD)
Filed: 2026-09-03 AccNo: 0001213900-26-097280 Size: 188 KB Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Modular Medical Says FDA Cleared Software Enhancements To Pivot Tubeless Patch Pump, Including Bolus Dosing Customization And User-Interface Upgrades, Ahead Of Planned Q4 Launch